38 results match your criteria: "Pitie-Salpetriere Hospital Paris[Affiliation]"

Discriminating factors in access to video-EEG for epilepsy surgery in a French tertiary epilepsy center.

Rev Neurol (Paris)

October 2024

Rehabilitation Unit, AP-HP, Pitié-Salpêtrière Hospital, Paris, France; AP-HP, Epileptology Unit, Reference Center for Rare Epilepsies, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Sorbonne Université, Paris, France; Paris Brain Institute (ICM), Inserm, CNRS, Pitié-Salpêtrière Hospital Paris, Paris, France. Electronic address:

Article Synopsis
  • Equitable access to epilepsy care varies by country, and a study in France aimed to identify factors affecting surgical access for patients with refractory medial temporal lobe epilepsy (MTLE-HS).
  • The study analyzed data from 293 patients, finding that only age at onset, pensioner status, and student status significantly influenced delays in accessing video-EEG, while migratory status and socio-economic factors did not.
  • The authors recommend that France enhance communication among healthcare practitioners to improve timely referrals for surgery, regardless of patients' demographics.
View Article and Find Full Text PDF

Background: Early negative life events (NLE) have long-lasting influences on neurodevelopment and psychopathology. Reduced orbitofrontal cortex (OFC) thickness was frequently associated with NLE and depressive symptoms. OFC thinning might mediate the effect of NLE on depressive symptoms, although few longitudinal studies exist.

View Article and Find Full Text PDF

Direct puncture embolization of a medulla oblongata hemangioblastoma.

J Neuroradiol

May 2024

Department of Neuroradiology, Pitié-Salpêtrière Hospital. Paris, France; GRC BioFast, Sorbonne University, Paris, France.

Hemangioblastoma is a rare tumor of vascular origin, most commonly located in the posterior fossa, which presents with severe symptoms and usually very hard to resect without remarkable operative blood loss. Pre-operative embolization may decrease the amount of intra-operative bleeding, but the endovascular treatment of such tumor may be very challenging due to the high risk of infarction of the surrounding tissues. Direct puncture embolization has been developed to overcome many of the limitations of endovascular techniques for many hypervascular lesions, also hemangioblastomas.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the first pass effect (FPE) in endovascular treatment (EVT) for medium vessel occlusion strokes, focusing on its predictors and impact on patient outcomes.
  • The analysis included 836 patients, revealing that FPE occurred in 36.1% and was linked to better functional outcomes as well as lower rates of mortality and intracranial hemorrhage.
  • FPE was significantly associated with favorable outcomes at 90 days, suggesting its importance in improving recovery and reducing complications in stroke patients.
View Article and Find Full Text PDF

Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration.

Br J Clin Pharmacol

December 2023

Department of Intensive Care and Dutch Poisons Information Centre, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.

Cefiderocol is a broad-spectrum cephalosporin antibiotic and is indicated in patients with difficult-to-treat Gram-negative bacterial infections. Cefiderocol is applied as a 2-4-times daily prolonged 3-h infusion. The therapeutic target of cefiderocol suggests that continuous infusion (CI) may be advantageous, since it is more likely to achieve 100% of time of the unbound concentration above the minimal inhibitory concentration (MIC).

View Article and Find Full Text PDF

Prognosis of Right Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy.

J Am Heart Assoc

August 2023

Service de Réanimation médicale et unité de ventilation à domicile CHU Raymond Poincaré, APHP, UVSQ Garches France.

Background Chronic respiratory failure and heart involvement may occur in Duchenne muscular dystrophy. We aimed to assess the prognostic value of the right ventricular (RV) systolic dysfunction in patients with Duchenne muscular dystrophy. Methods and Results We studied 90 genetically proven patients with Duchenne muscular dystrophy from 2010 to 2019, to obtain respiratory function and Doppler echocardiographic RV systolic function.

View Article and Find Full Text PDF

Can a failure in the error-monitoring system explain unawareness of memory deficits in Alzheimer's disease?

Cortex

September 2023

Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Laboratory of Brain Plasticity, CNRS UMR 8249, ESPCI Paris - PSL, Paris, France; FrontLab, Paris Brain Institute, ICM, Pitié Salpêtrière GH, 47 Bd de l'Hôpital, 75013, Paris, France. Electronic address:

Unawareness of memory deficits is an early manifestation in patients with Alzheimer's disease (AD), which often delays diagnosis. This intriguing behavior constitutes a form of anosognosia, whose neural mechanisms remain largely unknown. We hypothesized that anosognosia may depend on a critical synaptic failure in the error-monitoring system, which would prevent AD patients from being aware of their own memory impairment.

View Article and Find Full Text PDF

Early identification of seizure freedom with medical treatment in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

J Neurol

May 2023

Reference Center for Rare Epilepsies, Department of Neurology, Epileptology Unit, AP-HP, Pitié-Salpêtrière Hospital, 47-83, boulevard de l'hôpital, 75651, Paris Cedex 13, France.

Background: Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is usually associated with a poor response to antiseizure medications. We focused on MTLE-HS patients who were seizure free on medication to: (1) determine the clinical factors associated with seizure freedom and (2) develop a machine-learning classifier to better earlier identify those patients.

Methods: We performed a retrospective, multicentric study comparing 64 medically treated seizure-free MTLE-HS patients with 200 surgically treated drug-resistant MTLE-HS patients.

View Article and Find Full Text PDF
Article Synopsis
  • Ivuxolimab and utomilumab are monoclonal antibodies targeting OX40 and 4-1BB, respectively, and were tested in a phase I trial for safety, pharmacokinetics, and anti-tumor activity in patients with advanced solid tumors.
  • In the dose-escalation phase, 57 patients were treated, leading to a disease control rate of 35.1%, with some showing partial responses, particularly among those with melanoma.
  • The dose-expansion phase included 30 patients, where only one with NSCLC had a successful partial response that lasted over 77 weeks, indicating potential effectiveness but limited success overall.
View Article and Find Full Text PDF

Long-term deep intracerebral microelectrode recordings in patients with drug-resistant epilepsy: Proposed guidelines based on 10-year experience.

Neuroimage

July 2022

Sorbonne Université, Paris Brain Institute - Institut du Cerveau, ICM, INSERM, CNRS, APHP, Pitié-Salpêtrière Hospital, Paris France; AP-HP, EEG Unit, Neurophysiology Department, Pitié-Salpêtrière Hospital, DMU Neurosciences, Paris, France; AP-HP, Epilepsy Unit, Pitié-Salpêtrière Hospital, DMU Neurosciences, Paris, France; AP-HP, Center of Reference for Rare Epilepsies, Pitié-Salpêtrière Hospital, Paris, France. Electronic address:

Purpose: Human neuronal activity, recorded in vivo from microelectrodes, may offer valuable insights into physiological mechanisms underlying human cognition and pathophysiological mechanisms of brain diseases, in particular epilepsy. Continuous and long-term recordings are necessary to monitor non predictable pathological and physiological activities like seizures or sleep. Because of their high impedance, microelectrodes are more sensitive to noise than macroelectrodes.

View Article and Find Full Text PDF

Distinctive neuropsychological profiles of lateral temporal lobe epilepsy.

Epilepsy Behav

December 2021

Rehabilitation Unit, AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Epilepsy Unit, AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Université Paris Sorbonne, Paris, France; Centre de recherche de l'Institut du cerveau et de la moelle épinière (ICM), UMPC-UMR 7225 CNRS-UMRS 975 Inserm, Paris, France. Electronic address:

Objective: Lateral temporal lobe epilepsies (LTLE) are poorly characterized heterogeneous epilepsies. As the lateral temporal lobe supports distinct functions, we hypothesized that neuropsychological profiles could differ according to the localization of the seizure focus within the lateral temporal lobe.

Methods: We retrospectively examined the neuropsychological characteristics of 74 consecutive patients with refractory LTLE assessed in the context of a presurgical investigation at the Pitié-Salpêtrière Hospital in Paris between 1998 and 2018.

View Article and Find Full Text PDF

Background: A previous clinical study showed the high specificity, sensitivity and reliability of MSCopilot, a software medical device designed by Ad Scientiam for the self-assessment of people with Multiple Sclerosis (PwMS), compared to the traditional Multiple Sclerosis Functional Composite (MSFC). We conducted further analyses to assess MSCopilot's performance with respect to the Expanded Disability Status Scale (EDSS).

Methods: The data of 116 PwMS were analysed.

View Article and Find Full Text PDF

Background: Cognitive impairment is an important comorbidity of refractory temporal lobe epilepsy (TLE). We aimed to explore the impact of (i) specific lesions, such as dysembryoplastic neuroepithelial tumor (DNET), dysplasia, or hippocampal sclerosis, (ii) focus localization (medial versus lateral) and (iii) focus lateralization (right versus left) on the neuropsychological profile of refractory TLE adult patients.

Methods: We examined the neuropsychological characteristics of 312 adults with refractory TLE: 100 patients without hippocampal sclerosis (HS) and 212 with HS.

View Article and Find Full Text PDF

Background Mineralocorticoid receptor antagonists (MRAs) have emerged as potential atrial fibrillation (AF) preventive therapy, but inconsistent results have been reported. We aimed to examine the effects of MRAs on AF occurrence and explore factors that could influence the magnitude of the effect size. Methods and Results PubMed, Embase, and Cochrane Central databases were used to search for randomized clinical trials and observational studies addressing the effect of MRAs on AF occurrence from database inception through April 03, 2018.

View Article and Find Full Text PDF

Objective: Limb girdle muscular dystrophy type R9 (LGMD R9) is an autosomal recessive muscle disease for which there is currently no causative treatment. The development of putative therapies requires sensitive outcome measures for clinical trials in this slowly progressing condition. This study extends functional assessments and MRI muscle fat fraction measurements in an LGMD R9 cohort across 6 years.

View Article and Find Full Text PDF

Objective: We aimed to assess a cohort of young patients with Dravet syndrome (DS) for intellectual disability (ID) and autism spectrum disorder (ASD) using standardized tools and parental questionnaires to delineate their specific profiles.

Methods: We included 35 patients with DS aged 24 months to 7 years, excluding patients with a developmental age (DA) <18 months (n = 5). We performed specific tests adapted for ID (Psychoeducational Profile, Third Edition [PEP-3]), in addition to the Child Development Inventory (CDI) and Vineland Adaptive Behavior Scales, Second Edition (VABS-II) questionnaires.

View Article and Find Full Text PDF

We analyzed the number and functionality of regulatory B (Breg) cells in well-defined myasthenia gravis patients. We first showed a decreased number of circulating CD19 CD24 CD38 Breg cells and an altered functionality of Breg cells in untreated myasthenia gravis patients. Next, we demonstrated that the proportion of circulating Breg cells was restored in myasthenia gravis patients after thymectomy, probably as Breg cells could be sequestered in the myasthenia gravis thymus.

View Article and Find Full Text PDF

Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of non-vitamin K antagonist oral anticoagulant (NOAC) with antiplatelet therapy have been tested in several large phases II and III randomised trials. Overall, current evidence suggests that the use of NOACs on top of DAPT after ACS reduces the rate of recurrent ischaemic events, albeit at the price of increased risk for major bleeding.

View Article and Find Full Text PDF